Try Alerts Free   |   Login
Health Care › Pharmaceutical Preparations

Acadia Pharmaceuticals (ACAD) Financials and Smart Investor 13F Alerts

See how revenue, income, cash flow, and balance sheet financials have changed over 36 quarters since 2012. Compare with ACAD stock chart to see long term trends.

ACAD stock compared to

ACAD Income Statement

Revenue, Net:121007000
Revenue Per Share:0.77
Cost of Goods & Services Sold:2508000
Gross Profit:118499000
Selling, General & Admin Expense:120752000
Research & Development Expense:62116000
Total Operating Expenses:188169000
Operating Income:-71956000
Income Taxes:null
Net Income:-66760000
Earnings Per Share, Basic:-0.41
Shares Outstanding, Basic Avg:157331000

ACAD Cash Flow

Operating Activities Net Income:
Change in Accounts Receiveable:1903000
Net Cash from Operations:-27488000
Net Cash from Financing Activities:18126000
Property, Plant & Equipment Purchases:1999000
Net Cash from Investing Activities:-116958000
Net Change in Cash & Equivalents:-126324000

ACAD Balance Sheet

Cash and Cash Equivalents:331798000
Accounts Receivable, Net:48247000
Inventories:9682000
Total Current Assets:717616000
Property, Plant & Equipment, Net:9161000
Total Assets:782616000
Accounts Payable:8493000
Total Short-Term Liabilities:105967000
Total Liabilities:155607000

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
FMR LLC
19,748,348 sh
-1,041,956 sh
-5%
$814,619
-$193,087
Price T Rowe Associates Inc /Md/
10,537,138 sh
-804,648 sh
-7%
$434,657
-$115,079
Vanguard Group Inc
10,369,690 sh
-291,729 sh
-3%
$427,750
-$89,009
Blackrock Inc.
7,161,211 sh
-596,635 sh
-8%
$295,400
-$80,622
D. E. Shaw & Co., Inc.
2,264,513 sh
116,305 sh
5%
$93,411
-$10,713
Fred Alger Management, LLC
2,078,148 sh
864,840 sh
71%
$85,724
$26,915
Great Point Partners LLC
1,921,563 sh
116,570 sh
6%
$79,264
-$8,224
Ameriprise Financial Inc
1,216,007 sh
-950,967 sh
-44%
$50,160
-$54,868
American Century Companies Inc
1,205,846 sh
107,501 sh
10%
$49,741
-$3,496
Frontier Capital Management Co LLC
994,039 sh
-192,445 sh
-16%
$41,004
-$16,505
Goldman Sachs Group Inc
960,067 sh
936,067 sh
3900%
$39,603
$38,440
Charles Schwab Investment Management Inc
895,547 sh
160,482 sh
22%
$36,942
$1,313
UBS Asset Management Americas Inc
589,726 sh
-329,928 sh
-36%
$24,326,198
-$20,249,432
Northern Trust Corp
587,883 sh
-16,917 sh
-3%
$24,250
-$5,064
Bank Of America Corp /De/
492,439 sh
-49,786 sh
-9%
$20,313
-$5,968
International Biotechnology Trust Plc
486,000 sh
181,000 sh
59%
$20,048
$5,350
Morgan Stanley
485,639 sh
311,707 sh
179%
$20,032
$11,602
Boxer Capital, LLC
370,000 sh
 
$15,263
Invesco Ltd.
301,223 sh
-3,871 sh
-1%
$12,425
-$2,363
Renaissance Technologies LLC
269,500 sh
157,300 sh
140%
$11,117
$5,679

Data imported from Acadia Pharmaceuticals Inc SEC filings. Check original filings before making any investment decision.